Peters S P, Coyle P, Coffee C J, Glew R H
J Biol Chem. 1977 Jan 25;252(2):563-73.
Gaucher's disease is a lysosomal storage disease caused by a deficiency in the enzyme glucocerebrosidase. A small, heat-stable glycoprotein first obtained from Gaucher spleen (Ho, M. W., and O'Brien, J. S. (1971) Proc. Natl. Acad. Sci. U. S.A. 68, 2810-2813) has been observed to stimulate the activity of glucocerebrosidase isolated from normal tissue. It has been suggested that this material might be important in the physiological catabolism of glucocerebroside in normal individuals (Ho, M. W. (1974) in Enzyme Therapy in Lysosomal Storage Diseases (Tager, J. M., Hooghwinkel, G. J. M., and Daems, W. Th., eds) pp.239-246, North-Holland Publishing Co., Amsterdam). In order to investigate this suggestion, glucocerebrosidase activating factors were isolated and purified from control and Gaucher spleen and characterized. Although approximately the same mass of activator was isolated from both spleens, the two activators differ from one another in a number of important respects: (a) the activator from the control spleen is only 6 per cent as active (on a protein basis) as the activator from Gaucher spleen; (b) the amino acid compositions of the purified activators are significantly different; and (c) carbohydrate analysis of the purified activators indicates that the activator from Gaucher spleen is a glycoprotein, while that from control spleen is not. Comparative kinetic studies demonstrate that the anionic detergent, sodium taurocholate, and the acidic phospholipid, phosphatidylinositol, both stimulate glucocerebrosidase activity to a larger extent than the activator substance from Gaucher spleen. The activator from Gaucher spleen and human liver glucocerebrosidase both appear to contain significant hydrophobic character. We conclude that the activator is probably not physiologically important in the catabolism of glucocerebroside in normal tissues. The significance of the occurrence of this apparently unique glycoprotein activator in Gaucher spleen remains obscure; however, its presence represents another interesting aspect of Gaucher's disease that warrants further investigation.
戈谢病是一种由葡糖脑苷脂酶缺乏引起的溶酶体贮积病。一种最初从戈谢病脾脏中获得的、小的、热稳定糖蛋白(Ho,M. W.,和O'Brien,J. S.(1971年)《美国国家科学院院刊》68,2810 - 2813)已被观察到可刺激从正常组织中分离出的葡糖脑苷脂酶的活性。有人提出这种物质可能在正常个体中葡糖脑苷脂的生理分解代谢中起重要作用(Ho,M. W.(1974年)载于《溶酶体贮积病的酶疗法》(Tager,J. M.,Hooghwinkel,G. J. M.,和Daems,W. Th.编)第239 - 246页,北荷兰出版公司,阿姆斯特丹)。为了研究这一观点,从对照脾脏和戈谢病脾脏中分离并纯化了葡糖脑苷脂酶激活因子,并对其进行了表征。尽管从两种脾脏中分离出的激活剂质量大致相同,但这两种激活剂在许多重要方面彼此不同:(a)对照脾脏中的激活剂(以蛋白质计)活性仅为戈谢病脾脏中激活剂的6%;(b)纯化后的激活剂的氨基酸组成有显著差异;(c)对纯化后的激活剂的碳水化合物分析表明,戈谢病脾脏中的激活剂是一种糖蛋白,而对照脾脏中的激活剂不是。比较动力学研究表明,阴离子去污剂牛磺胆酸钠和酸性磷脂磷脂酰肌醇对葡糖脑苷脂酶活性的刺激程度均大于戈谢病脾脏中的激活剂物质。戈谢病脾脏中的激活剂和人肝脏葡糖脑苷脂酶似乎都具有显著的疏水特性。我们得出结论,该激活剂在正常组织中葡糖脑苷脂的分解代谢中可能在生理上并不重要。这种明显独特的糖蛋白激活剂在戈谢病脾脏中出现的意义仍不清楚;然而,它的存在代表了戈谢病另一个有趣的方面,值得进一步研究。